DEFA14A: Four Leaf Acquisition Corporation Discloses Critical Foreign Ownership and Nasdaq Delisting Risks
Definitive Additional Materials
Four Leaf Acquisition Corporation has filed additional proxy materials, revealing significant risks related to foreign ownership potentially impacting U.S. business combinations and a potential Nasdaq delisting if its proposed extension beyond 36 months is approved.
Summary
- Four Leaf Acquisition Corporation (Four Leaf) filed definitive additional proxy materials on June 24, 2025, to supplement its definitive proxy statement dated June 13, 2025, for a special meeting of stockholders scheduled for June 22, 2025.
- The filing amends and restates risk factors concerning potential U.S. foreign investment regulations and review by the Committee on Foreign Investment in the United States (CFIUS).
- Mr. Alvin Wang, a resident of the Peoples Republic of China (PRC) and a member of Four Leaf's Board of Directors, holds 81.4% of the outstanding membership interests in the company's Sponsor, which in turn owns approximately 33.2% of Four Leaf's outstanding shares.
- This significant foreign influence may cause Four Leaf to be considered a foreign person, potentially subjecting any proposed business combination with a U.S. target company (especially those in regulated industries or affecting national security) to foreign ownership restrictions and/or CFIUS review, which could limit the pool of acquisition candidates, delay, or prohibit transactions.
- New disclosures highlight a risk of Nasdaq delisting: the company's IPO registration statement was effective on March 16, 2023, meaning it must complete a business combination by March 16, 2026, to comply with Nasdaq's 36-month rule (IM-5101-2(b)).
- Four Leaf is seeking to extend its Amended Termination Date to June 22, 2026, which would be 39 months after its IPO, explicitly not complying with Nasdaq Listing Rule IM-5101-2 as currently in force.
- If delisted from Nasdaq, the company's securities would likely trade on an over-the-counter market, facing significant adverse consequences including limited market quotations, designation as a 'penny stock', reduced trading activity, limited news and analyst coverage, and decreased ability to issue additional securities or obtain future financing.
- If the initial business combination is not completed by the Current Termination Date (June 22, 2025) or the Amended Termination Date (June 22, 2026, if the Extension is approved), the company will liquidate, redeem public shares, and its warrants will expire worthless.
Sentiment
Score: 2
Explanation: The document primarily details significant risks, including potential delisting from Nasdaq and challenges related to foreign ownership and CFIUS review, which could severely impede the company's ability to complete a business combination and lead to liquidation. No positive developments or financial improvements are disclosed.
Negatives
- Significant foreign ownership by a PRC resident (Mr. Alvin Wang) could subject potential U.S. business combinations to stringent CFIUS review, potentially limiting the pool of acquisition targets or blocking transactions.
- The proposed extension of the business combination deadline to June 22, 2026, would exceed Nasdaq's 36-month rule (March 16, 2026), leading to a high risk of delisting from Nasdaq.
- Delisting would result in severe adverse consequences, including limited market liquidity, 'penny stock' designation, reduced trading, and impaired ability to raise future capital.
- Failure to complete a business combination by the extended deadline will result in liquidation, redemption of public shares, and warrants expiring worthless.
Risks
- **CFIUS Review and Foreign Ownership Restrictions:** Due to Mr. Alvin Wang's 81.4% ownership in the Sponsor (which owns 33.2% of Four Leaf's shares), Four Leaf may be considered a foreign person, subjecting potential U.S. business combinations (especially in regulated or national security industries) to CFIUS review, potentially limiting the pool of acquisition candidates, delaying, or prohibiting transactions.
- **Nasdaq Delisting Risk:** Extending the business combination deadline beyond March 16, 2026 (36 months from IPO effectiveness) to June 22, 2026, would violate Nasdaq Listing Rule IM-5101-2, leading to potential suspension and delisting of securities.
- **Consequences of Delisting:** If delisted, securities would trade on an over-the-counter market, facing limited market quotations, 'penny stock' designation, reduced trading activity, limited news/analyst coverage, and decreased ability to issue additional securities or obtain financing.
- **Liquidation Risk:** Failure to complete an initial business combination within the specified Combination Period (June 22, 2025, or June 22, 2026 if extension approved) will result in the company's liquidation, redemption of public shares, and warrants expiring worthless.
- **Limited Timeframe:** The company has a limited time to complete its initial business combination, and delays due to CFIUS review or other factors could lead to liquidation.
Future Outlook
The company's future outlook is highly dependent on the approval of the Extension Proposals by stockholders and its ability to successfully complete an initial business combination within the extended timeframe, while navigating significant foreign ownership and Nasdaq listing compliance challenges. Failure to do so will result in liquidation.
Industry Context
This filing highlights critical challenges faced by Special Purpose Acquisition Companies (SPACs) operating under evolving regulatory landscapes, particularly concerning foreign investment scrutiny (CFIUS) and stringent stock exchange listing rules (Nasdaq's 36-month rule). It underscores the increasing complexity and risks associated with completing de-SPAC transactions, especially for SPACs with significant foreign ownership or those seeking extensions beyond standard timelines, which can lead to delisting and reduced market access.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Risk Factor Amendment | The risk factor regarding potential U.S. foreign investment regulations and CFIUS review has been amended and restated to explicitly mention Mr. Alvin Wang's significant ownership in the Sponsor and the potential impact on business combinations. | 2025-06-24 | Increases transparency regarding specific foreign ownership risks that could impede the company's ability to complete a business combination. |
Related Party Transactions
- Mr. Alvin Wang, a member of the Board of Directors and a resident of the Peoples Republic of China, holds 81.4% of the outstanding membership interests in the Sponsor, which directly influences the Sponsor. The Sponsor currently owns approximately 33.2% of the company's outstanding shares.
Stakeholder Impact
- **Shareholders:** Face significant risk of delisting from Nasdaq, which would severely limit market liquidity and potentially reduce share value. Their voting decision on the Extension Proposals is critical for the company's future. If a business combination is not completed, public shares will be redeemed, but at a per-share price based on the Trust Account, extinguishing further rights.
- **Warrant Holders:** Warrants will expire worthless if the company liquidates due to failure to complete a business combination, with no redemption rights or liquidating distributions.
- **Potential Target Companies:** The pool of potential U.S. acquisition targets may be limited due to foreign ownership restrictions and the potential for lengthy CFIUS review, making the company a less attractive partner compared to SPACs without similar issues.
Next Steps
- Stockholders to vote on Extension Proposals at the Special Meeting on June 22, 2025.
- Company to complete an initial business combination by the Current Termination Date (June 22, 2025) or the Amended Termination Date (June 22, 2026) if the Extension is approved.
- If a business combination is not completed within the Combination Period, the company will liquidate, redeem public shares, and dissolve.
Key Dates
| Date | Description |
|---|---|
| 2023-03-16 | Effectiveness date of IPO registration statement on Form S-1. |
| 2025-06-13 | Date of the Definitive Proxy Statement. |
| 2025-06-22 | Scheduled date for the Special Meeting of stockholders and Current Termination Date for business combination. |
| 2025-06-24 | Date of Supplement No. 1 to the Definitive Proxy Statement. |
| 2026-03-16 | 36-month deadline for completing a business combination according to Nasdaq Listing Rule IM-5101-2. |
| 2026-06-22 | Proposed Amended Termination Date if Extension Proposals are approved. |
Recommendation
sellKeywords
SPAC, Four Leaf Acquisition Corporation, DEFA14A, Proxy Statement, CFIUS, Foreign Investment, National Security, Nasdaq Delisting, Business Combination, Special Purpose Acquisition Company, Risk Factors, Corporate Governance, Liquidation, Warrants, Shareholder Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.